Stanford cancer immunology. The laboratory Feb 24, 2026 · Open access publisher of peer-reviewed scientific articles across the entire spectrum of academia. D. Our students benefit greatly from the Dec 15, 2025 · Immunology December 15, 2025 Stanford Medicine study identifies immune switch critical to autoimmunity, cancer By Krista Conger A molecule involved in red blood cell production determines whether the immune system attacks or ignores cells in the body via peripheral immune tolerance, Stanford Medicine researchers find. The Ross Laboratory is led by Jason Ross, MD, PhD, and is situated within the Stanford University School of Medicine's Department of Radiation Oncology. Rituximab, the first FDA approved monoclonal antibody for the treatment of cancer and now used to treat lymphoma and many autoimmune diseases, was developed based on the work of Stanford physician scientist Ronald Levy, MD. Stanford is committed to partnering with communities to remove barriers to participation. The Parker Institute for Cancer Immunotherapy coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. Fundamental modeling Research at Stanford has led to the development of a number of targeted therapies that are now FDA approved: 1. The primary goal of the program is to provide outstanding training and education and graduating productive and innovative young scientists prepared for successful careers in immunology and related disciplines. ZABA LAB VIEW OUR WORK We utilize systems immunology and artificial intelligence to explore the interaction between the human immune system and cancer in order to personalize and optimize each patient’s cancer care. . Provenge, t Jan 14, 2026 · In a Jan. 4 hours ago · Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies. ’92 discussed his lab’s research enhancing internal immune Stanford Medicine Stanford Medicine develops novel therapies in cancer immunology with a focus on cell therapy Stanford Medicine ‘s history in cancer immunotherapy dates back to the 1980s – from researching personalized anticancer antibodies to treating pediatric leukemia with T-cells. Research network for academics to stay up-to-date with the latest scientific publications, events, blogs and news. Our research is highly translational, using imaging, immune cells, and genetic information from patients to further understand how an individual’s immune system responds to Stanford Medicine Stanford Medicine develops novel therapies in cancer immunology with a focus on cell therapy Stanford Medicine ‘s history in cancer immunotherapy dates back to the 1980s – from researching personalized anticancer antibodies to treating pediatric leukemia with T-cells. Fundamental modeling Stanford is committed to partnering with communities to remove barriers to participation. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong M. These advances have coincided with an exponential growth in the development of -omics technologies. The Cancer Immunotherapy Program brings together basic scientists, translational investigators and clinician scientists to discover fundamental principles that regulate immune responses to cancer and to translate this understanding into novel cancer therapies. The Stanford Immunology Interdepartmental Program (IDP) offers interdisciplinary training in research and teaching leading to a Ph. The Stanford Cancer Institute has scientific strengths in cancer cell and stem cell biology, radiation biology, genetics and genomics, immunology and immunotherapy, and molecular imaging. Jul 12, 2021 · Aging & Geriatrics July 12, 2021 Immune system 'clock' predicts illness and mortality By Bruce Goldman Scientists at Stanford and the Buck Institute have found a way to predict an individual's immunological decline as well as the likelihood of incurring age-associated diseases and becoming frail. A major focus is on comprehensive immune profiling, using tools for high dimensional analysis of immune responses. Our program includes physician scientists working across multiple cancer types to develop innovative treatments and delivery mechanisms with the potential to provide durable, robust cancer immune responses. in Immunology. Jul 13, 2020 · Tumor immunology is undergoing a renaissance due to the recent profound clinical successes of tumor immunotherapy. Stanford Cancer Immunotherapy Program The Stanford Cancer Immunotherapy Program is finding new ways to harness the immune system to fight cancer. The Cancer Immunotherapy Program brings together basic scientists, translational investigators and clinician scientists to discover fundamental principles that regulate immune responses to cancer and to translate this understanding into novel cancer therapies. 2. Our efforts are advancing: patient-specific By uncovering the mechanisms behind both cancer's biology and our immune system, Stanford clinicians and researchers are developing new strategies to thwart cancer's ability to evade successful treatment: genetic profiling of each patient's cancer and novel therapies called immunotherapy. Armed with these technologies and their associated computational and modeling toolset … The Cancer Immunotherapy Program brings together basic scientists, translational investigators and clinician scientists to discover fundamental principles that regulate immune responses to cancer and to translate this understanding into novel cancer therapies. Fundamental modeling Jan 27, 2026 · The Ross Laboratory at Stanford University is seeking a Life Science Research Professional 1 to perform basic functions and activities involved in defined research projects, and independently conduct and analyze experiments. srdnyr vknahl etoe mdekk pqewsr ttevjz ypfvv gbnjqw aok izkhcn